[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"learn-detail:webinars:medicinal-cannabis-in-advanced-paediatric-cancers-evidence-and-recommendations":3},{"id":4,"slug":5,"title":6,"excerpt":7,"image_url":8,"cpd_points":9,"duration_minutes":10,"starts_at":11,"type":12,"hero_image_url":13,"body_html":7,"learning_outcomes":14,"learning_outcomes_heading":18,"about":19,"speakers":22,"cta":30,"sponsors":34,"cpd_activity":49,"related":52},"38","medicinal-cannabis-in-advanced-paediatric-cancers-evidence-and-recommendations","Medicinal Cannabis in Advanced Paediatric Cancers: Evidence and Recommendations","Join us for an insightful webinar presented by Alison Bowers, a leading researcher in paediatric palliative care. This session will explore the potential benefits and considerations of using medicinal cannabis (MC) for children with advanced cancers.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002FWebinar_Medicinal_Cannabis_in_Advanced_Paediatric_Cancers_Evidence_and_Recommendationss_COVER_OVERLAY.webp",1,60,"2024-11-05T19:00:00+11:00","webinars","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002Fhero-images\u002FWebinar_Medicinal_Cannabis_in_Advanced_Paediatric_Cancers_Evidence_and_Recommendationss_HERO_OVERLAY.webp",[15,16,17],"Summarise the complexities and obstacles involved in initiating a randomised controlled trial for medicinal cannabis in paediatric palliative care settings.","Evaluate the existing research and foundational evidence supporting the use of medicinal cannabis for children with advanced cancers, including its potential benefits and considerations.","Assess the significance of incorporating the views of children and their parents regarding medicinal cannabis use, contributing to a more holistic understanding of this treatment approach in paediatric care.","Learning Outcomes",{"heading":20,"body_html":21},"About the webinar","Join us for an insightful webinar presented by Alison Bowers, a leading researcher in the field of paediatric palliative care. This session will explore the potential benefits and considerations of using medicinal cannabis (MC) for children with advanced cancers. Alison will discuss the principles and challenges of setting up a groundbreaking randomised controlled trial, highlighting the background evidence for medicinal cannabis in paediatric care. While the trial has faced several delays and no results are available yet, the webinar will provide a comprehensive overview of the foundational aspects and ongoing efforts to investigate this emerging treatment option.",{"heading":23,"items":24},"About the speaker",[25],{"name":26,"position":27,"bio_html":28,"image_url":29},"Dr Alison Bowers","Registered General Nurse","Dr Bowers is a Registered Children’s Nurse (United Kingdom) and Registered General Nurse (Australia). She currently works as a Research Fellow in the Cancer and Palliative Care Outcomes Centre, within the Centre for Healthcare Transformation at Queensland University of Technology, Brisbane, Australia. Her research focus is paediatric palliative care, and she has a particular interest in health services research, large data and medicinal cannabis. Dr Bowers is a Chief Investigator, Project Manager and Trial Coordinator for the 'MINI Trial', a medicinal cannabis clinical trial for children with advanced cancer, an Associate Investigator and Project Manager for the evaluation of the Queensland Paediatric Palliative Care Outreach Collaborative and the project team lead for a needs analysis and gap-analysis in the delivery of Paediatric Palliative Care across Australia. Dr Bowers is also a Director for the Australian College of Children and Young People’s Nurses.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002Fspeakers\u002Fimages.jpeg",{"published":31,"on_demand":32,"is_free":32,"price":33},false,true,0,[35,40,44],{"name":36,"logo_url":37,"level":38,"website_url":39},"Tilray Australia","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fsponsors\u002Flogos\u002FTilray-logo.png","premium","https:\u002F\u002Fwww.tilray.com.au",{"name":41,"logo_url":42,"level":38,"website_url":43},"Cannatrek","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fsponsors\u002Flogos\u002Fcannatrek-logo (2).png","https:\u002F\u002Fcannatrek.com.au",{"name":45,"logo_url":46,"level":47,"website_url":48},"SomaÍ Pharmaceuticals","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fsponsors\u002Flogos\u002FSomai_Logo2.png","basic","https:\u002F\u002Fsomaipharma.com.au",{"description_html":50,"badge_url":51},"Medihuanna is a CPD approved education provider, and this activity has been approved by the RACGP (Activity ID: 977307). Upon completing this activity, you will be eligible to claim CPD hours. The activity will include the following CPD allocation which will be uploaded to the RACGP dashboard.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002Fbadges\u002FCPD_Approved_Activity_EA_1_24_11_05.jpeg",[53,60,67,74],{"id":54,"slug":55,"title":56,"excerpt":57,"image_url":58,"cpd_points":9,"starts_at":59,"type":12},"50","pastilles-in-clinical-practice","Pastilles in Clinical Practice: Optimising Precision Dosing, Adherence and Patient Outcomes","Explore the clinical role of cannabis pastilles, including precision dosing, patient selection, adherence, safety and the evolving evidence for major and minor cannabinoids.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002FCover_Pastilles-80.webp","2026-11-19T19:00:00+11:00",{"id":61,"slug":62,"title":63,"excerpt":64,"image_url":65,"cpd_points":9,"starts_at":66,"type":12},"52","beyond-the-dose-understanding-oral-cannabinoid-therapy","Beyond the Dose: Understanding Oral Cannabinoid Therapy","Explore how formulation, absorption and metabolism influence the bioavailability and clinical effects of oral THC and CBD. This webinar examines key pharmacokinetic principles, emerging delivery technologies and published evidence to inform formulation selection, dosing and patient monitoring.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002FBeyond_the_Dose_A.webp","2026-12-02T19:00:00+11:00",{"id":68,"slug":69,"title":70,"excerpt":71,"image_url":72,"cpd_points":9,"starts_at":73,"type":12},"51","emerging-therapeutics-for-bpsd","Emerging Therapeutics for Behavioural and Psychological Symptoms of Dementia","Explore evidence-based management of behavioural and psychological symptoms of dementia and the emerging role of cannabinoid-based medicines.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002FCover_Emerging_Dementia-80.webp","2026-10-29T19:00:00+11:00",{"id":75,"slug":76,"title":77,"excerpt":78,"image_url":79,"cpd_points":9,"starts_at":80,"type":12},"49","thcv-and-metabolic-health","THCV and Metabolic Health: Exploring the Evidence and Clinical Potential","Explore the emerging role of Δ9-tetrahydrocannabivarin (THCV) in metabolic health, including its potential influence on appetite regulation, glucose metabolism and weight management. This session reviews THCV pharmacology, CB1 signalling, current preclinical and human evidence, and the key limitations shaping its potential future clinical application.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002FTHCV_Metabolic_overl-80.jpg","2026-08-27T19:00:00+10:00"]